Photodynamic Therapy for Nonmelanoma Skin Cancer-and More?

Archives of Dermatology

Volumn 140, Issue 1, 2004, Pages 116-120

  Morton, Colin A ^a  

^a Ward 17 Falkirk Community Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; BENZOPORPHYRIN DERIVATIVE; PHOTOSENSITIZING AGENT;

BLUE LIGHT; EDITORIAL; HUMAN; PHOTODYNAMIC THERAPY; PHOTODYNAMICS; PHOTOSENSITIZATION; PRIORITY JOURNAL; RED LIGHT; SKIN CANCER; TARGET CELL; TREATMENT INDICATION; TREATMENT OUTCOME;

FACIAL DERMATOSES; HUMANS; KERATOSIS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SCALP DERMATOSES; SKIN AGING; SKIN NEOPLASMS; SUNLIGHT;

EID: 0346499495     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.140.1.116     Document Type: Editorial

References (36)

1. Hopper C. Photodynamic therapy: a clinical reality in the treatment of cancer. Lancet Oncol. 2000;1:212-219.
2. Daniell MD, Hill JS. A history of photodynamic therapy. Aust N Z J Surg. 1991; 61:340-348.
3. Dougherty TJ, Kaufman JE, Goldfarb A, et al. Photoradiation therapy for the treatment of malignant tumours. Cancer Res. 1978;38:2628-2635.
4. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B. 1990;6:143-148.
5. Peng Q, Soler AM, Warloe T, et al. Selective distribution of porphyrins in thick basal cell carcinoma after topical application of methyl 5-aminolevulinate. J Photochem Photobiol B. 2001;62:140-145.
6. Fritsch C, Homey B, Stahl W, et al. Preferential relative porphyrin enrichment in solar keratoses upon topical application of 5-aminolaevulinic acid methylester. Photochem Photobiol. 1998;68:218-221.
7. Henderson BW, Dougherty TJ. How does photodynamic therapy work? Photochem Photobiol. 1992;55:145-157.
8. Brancaleon L, Moseley H. Laser and non-laser light sources for photodynamic therapy. Lasers Med Sci. 2002;17:173-186.
9. Alexiades-Armenakas MR, Geronemus RG. Laser-assisted photodynamic therapy of actinic keratoses. Arch Dermatol. 2003;139:1313-1320.
10. Morton CA, Brown SB, Collins C, et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol. 2002; 146:552-567.
11. Kurwa HA, Yong-Gee SA, Seed PT, et al. A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratoses. J Am Acad Dermatol. 1999;41:414-418.
12. Piacquadio DJ, Chen DM, Farber HF, et al. Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3 multicenter trials. Arch Dermatol. 2004;140:41-46.
13. Touma D, Yaar M, Whitehead S, Konnikov N, Gilchrest BA. A trial of short incubation broad-area photodynamic therapy for treatment of facial actinic keratoses and diffuse photodamage. Arch Dermatol. 2004;140:33-40.
14. Ruiz-Rodriguez R, Sanz-Sánchez T, Córdoba S. Photodynamic rejuvenation. Dermatol Surg. 2002;28:742-744.
15. Szeimies M, Karrer S, Radakovic-Fijan S, et al. Photodynamic therapy using topical methyl-5-aminolevulinate compared with cryotherapy for actinic keratosis: a prospective, randomized study. J Am Acad Dermatol. 2002;47:258-262.
16. Foley P, Freeman M, Vinciullo C, et al. A comparison of photodynamic therapy using Metvix with cryotherapy in actinic keratosis [abstract]. J Eur Acad Dermatol Venereol. 2001;15(suppl 2):223.
17. Pariser DM, Lowe NJ, Stewart DM, et al. Photodynamic therapy with topical methyl aminolevulinate for actinic keratoses: results of a prospective randomized multicenter trial. J Am Acad Dermatol. 2003;48:227-232.
18. Morton CA, Whitehurst C, McColl JH, et al. Photodynamic therapy for large or multiple patches of Bowen's disease and basal cell carcinoma. Arch Dermatol. 2001;137:319-324.
19. Morton CA, Whitehurst C, Moseley H, et al. Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. Br J Dermatol. 1996;135: 766-771.
20. Salim A, Leman JA, McColl JH, et al. Randomized comparison trial of photodynamic therapy with topical 5-fluorouracil in Bowen's disease. Br J Dermatol. 2003; 148:539-543.
21. Peng Q, Warloe T, Berg K, et al. 5-ALA based photodynamic therapy. Cancer. 1997;79:2282-2308.
22. Thissen MR, Schroeter CA, Neumann HA. Photodynamic therapy with delta-aminolaevulinic acid for nodular basal cell carcinomas using a prior debulking technique. Br J Dermatol. 2000;142:338-339.
23. Haller JC, Cairnduff F, Slack G, et al. Routine double treatments of superficial basal cell carcinomas using aminolaevulinic acid-based photodynamic therapy. Br J Dermatol. 2000;143:1270-1274.
24. Rhodes LE, de Rie M, Enström Y, et al. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Arch Dermatol. 2004;140:17-23.
25. Leman JA, Morton CA, MacKie RM. Treatment of superficial basal cell carcinomas with topical photodynamic therapy: recurrence rates and outcome [abstract]. Br J Dermatol. 2001;145(suppl 59):17.
26. Soler AM, Warloe T, Berner A, Giercksky KE. A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated by methyl 5-aminolaevulinate-based photodynamic therapy along with prior curettage. Br J Dermatol. 2001;145:467-471.
27. Lui H, Hobbs L, Tope WD, et al. Photodynamic therapy of multiple nonmelanoma skin cancers with verteporfin and red light-emitting diodes: two-year results evaluating tumor response and cosmetic outcomes. Arch Dermatol. 2004; 140:26-32.
28. Kalka K, Merk H, Mukhtar H. Photodynamic therapy in dermatology. J Am Acad Dermatol. 2000;42:389-413.
29. Grapengiesser S, Gudmundsson F, Larko O, et al. Pain caused by photodynamic therapy of skin cancer. Clin Exp Dermatol. 2002;27:493-497.
30. Rud E, Gederaas O, Hogset A, Berg K. 5-Aminolaevulinic acid, but not 5-aminolaevulinic acid esters, is transported into adenocarcinoma cells by system BETA transporters. Photochem Photobiol. 2000;71:640-647.
31. Wiegell S, Stender IM, Na R, Wulf HC. Pain associated with photodynamic therapy using topical ALA or ALA-methylester. Arch Dermatol. 2003;139:1173-1177.
32. Morton CA. The emerging role of 5-ALA-PDT in dermatology: is PDT superior to standard treatments? J Dermatolog Treat. 2002;13(suppl 1):S25-S29.
33. Leman JA, Dick DC, Morton CA. Topical 5-ALA photodynamic therapy for the treatment of cutaneous T-cell lymphoma. Clin Exp Dermatol. 2002;27:516-518.
34. Ibbotson SH. Topical 5-aminolaevulinic acid photodynamic therapy for the treatment of skin conditions other than non-melanoma skin cancer. Br J Dermatol. 2002;146:178-188.
35. Wulf HC, Stender IM, Bearda Bakker-Wensveen CAH, Pavel S. Metvix photodynamic therapy delays occurrence of new skin lesions in organ transplant recipients: a prospective, randomised and controlled study. Presented at: 9th World Congress on Cancers of the Skin; May 7-10, 2003; Seville, Spain.
36. Fritsch C, Lang K, Neuse W, Ruzicka T, Lehmann P. Photodynamic diagnosis and therapy in dermatology. Skin Pharmacol Appl Skin Physiol. 1998;11:358-373.